increased glutathione in acute myeloid leukemia Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for | Current Treatment Options Oncology ABCC1 and glutathione metabolism limit
ABCC1 and glutathione metabolism limit the efficacy of BCL 2 inhibitors in acute myeloid leukemia Nature Communications Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells ScienceDirect Metabolic Plasticity of Acute Myeloid Leukemia Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



